Cross-chiral exponential amplification of an RNA enzyme.
RNA ligase
RNA replication
chirality
directed evolution
ribozyme
Journal
Proceedings of the National Academy of Sciences of the United States of America
ISSN: 1091-6490
Titre abrégé: Proc Natl Acad Sci U S A
Pays: United States
ID NLM: 7505876
Informations de publication
Date de publication:
29 Oct 2024
29 Oct 2024
Historique:
medline:
22
10
2024
pubmed:
22
10
2024
entrez:
22
10
2024
Statut:
ppublish
Résumé
An RNA ligase ribozyme that catalyzes the joining of RNA molecules of the opposite chiral handedness was optimized for the ability to synthesize its own enantiomer from two component fragments. The mirror-image D- and L-ligases operate in concert to provide a system for cross-chiral replication, whereby they catalyze each other's synthesis and undergo mutual amplification at constant temperature, with apparent exponential growth and a doubling time of about 1 h. Neither the D- nor the L-RNA components alone can achieve autocatalytic self-replication. Cross-chiral exponential amplification can be continued indefinitely through a serial-transfer process that provides an ongoing supply of the component D- and L-substrates. Unlike the familiar paradigm of semiconservative nucleic acid replication that relies on Watson-Crick pairing between complementary strands, cross-chiral replication relies on tertiary interactions between structured nucleic acids "across the mirror." There are few examples, outside of biology, of autocatalytic self-replication systems that undergo exponential amplification and there are no prior examples, in either biological or chemical systems, of cross-chiral replication enabling exponential amplification.
Identifiants
pubmed: 39436654
doi: 10.1073/pnas.2413668121
doi:
Substances chimiques
RNA, Catalytic
0
RNA Ligase (ATP)
EC 6.5.1.3
RNA
63231-63-0
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
e2413668121Subventions
Organisme : NSF (NSF)
ID : MCB2114588
Organisme : HHS | NIH | National Institute of General Medical Sciences (NIGMS)
ID : F32GM146435
Déclaration de conflit d'intérêts
Competing interests statement:The authors declare no competing interest.